Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · IEX Real-Time Price · USD
3.230
-0.140 (-4.15%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $272.04 million as of July 2, 2024. Its market cap has decreased by -13.94% in one year.
Market Cap
272.04M
Enterprise Value
-267.24M
1-Year Change
-13.94%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $272.04M, a decrease of -85.96%. That is a compound annual growth rate of -41.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 272.00M | 6.88% |
| Dec 29, 2023 | 254.50M | -36.47% |
| Dec 30, 2022 | 400.60M | -46.08% |
| Dec 31, 2021 | 742.90M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.12% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 284.35M |
| Accolade | 282.43M |
| Procaps Group | 282.06M |
| LifeMD | 275.14M |
| Inozyme Pharma | 273.40M |
| Tactile Systems Technology | 268.99M |
| Orchestra BioMed Holdings | 266.27M |
| MacroGenics | 256.80M |